Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
23 studies found for:    Open Studies | "Tuberous Sclerosis"
Show Display Options
Rank Status Study
1 Recruiting A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous Sclerosis
Condition: Tuberous Sclerosis
Interventions: Drug: Placebo;   Drug: Everolimus (RAD001)
2 Recruiting Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Condition: Tuberous Sclerosis Complex
Intervention:
3 Recruiting Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
Condition: Tuberous Sclerosis Complex
Intervention: Behavioral: JASPER
4 Not yet recruiting Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
Condition: Tuberous Sclerosis Complex
Interventions: Drug: Vigabatrin;   Drug: Placebo
5 Recruiting Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France
Condition: Tuberous Sclerosis Complex
Intervention:
6 Recruiting Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers
Conditions: Renal Angiomyolipomas;   Tuberous Sclerosis
Intervention: Drug: Propranolol
7 Recruiting Study of Skin Tumors in Tuberous Sclerosis
Conditions: Hereditary Neoplastic Syndrome;   Tuberous Sclerosis
Intervention:
8 Recruiting A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Conditions: Tuberous Sclerosis Complex;   Seizures
Interventions: Drug: GWP42003-P;   Drug: Placebo
9 Recruiting Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy - Tuberous Sclerosis Complex
Conditions: TSC;   Tuberous Sclerosis Complex;   Epilepsy
Intervention: Device: epilepsy early diagnosis protocol
10 Not yet recruiting Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
Condition: Tuberous Sclerosis Complex (TSC)
Intervention: Drug: everolimus
11 Recruiting Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma
Conditions: Tuberous Sclerosis;   Lymphangioleiomyomatosis;   Angiomyolipoma
Intervention:
12 Recruiting Genetic Heterogeneity and Genotype-phenotype Correlation of Children and Adults With Tuberous Sclerosis Complex
Conditions: Sclerosis Tuberosa;   Tuberous Sclerosis Complex;   Cerebral Sclerosis;   Nervous System Disorders
Intervention:
13 Recruiting Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
Conditions: Tuberous Sclerosis;   Autism Disorder;   Intellectual Disability
Intervention:
14 Not yet recruiting Long-term Trial of Topical Sirolimus to Angiofibroma in Patient With Tuberous Sclerosis Complex
Conditions: Tuberous Sclerosis;   Angiofibroma;   Hypomelanotic Macule;   Plaque
Intervention: Drug: NPC-12G gel
15 Not yet recruiting Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC)
Conditions: Tuberous Sclerosis;   Angiofibroma;   Hypomelanotic Macule;   Plaque
Interventions: Drug: NPC-12G gel;   Drug: Placebo gel
16 Recruiting Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex
Conditions: Tuberous Sclerosis Complex;   TSC Related Cognitive Disability;   TSC Related Autism;   TSC Related Learning Problems
Interventions: Drug: Everolimus;   Drug: Placebo
17 Recruiting Safety of Simvastatin in LAM and TSC
Conditions: Lymphangioleiomyomatosis;   Tuberous Sclerosis Complex
Intervention: Drug: Simvastatin
18 Recruiting The Cognitive Variability in NF1 and TSC Monozygotic Twins
Conditions: Neurofibromatosis Type I;   Tuberous Sclerosis Complex
Intervention:
19 Not yet recruiting Topical Everolimus in Patients With Tuberous Sclerosis Complex
Condition: Facial Angiofibromas
Interventions: Drug: Everolimus;   Drug: Placebo
20 Recruiting A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD
Conditions: Epilepsy;   Tuberous Sclerosis Complex;   Focal Cortical Dysplasia
Intervention: Drug: Everolimus

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.